Europe Chemotherapy Market Size, Status and Forecast 2014-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Chemotherapy market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.5% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Chemotherapy Market Segmentations:

    By Player:

    • F. Hoffmann-La Roche Ltd.

    • ALZA Corporation.

    • OSI Pharmaceuticals, Inc.

    • AstraZeneca PlC

    • Genentech Inc

    • Takeda Pharmaceutical Company

    • Dendreon Corporation.

    • Medimmune, LLC

    • Progenics Pharmaceuticals, Inc.

    • Immunomedics, Inc

    • Cell Genesys Inc.

    • Paladin Labs Inc

    • Bristol-Myers Squibb Company.

    • Indevus Pharmaceuticals Inc

    • Sanofi-Aventis SA.

    • EUSA Pharma, Inc

    • F Hoffmann-La Roche Ltd

    • Spectrum Pharmaceuticals, Inc.

    • Novartis AG (Switzerland).

    • Pfizer Inc.

    • GlaxoSmithKline PIC.

    • Amgen Inc

    By Type:

    • Paclitaxel

    • Vincristine

    • Others

    By End-User:

    • Hospitals

    • Research institutes

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Chemotherapy Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Chemotherapy Market Size and Growth Rate of Paclitaxel from 2014 to 2026

    • 1.3.2 Europe Chemotherapy Market Size and Growth Rate of Vincristine from 2014 to 2026

    • 1.3.3 Europe Chemotherapy Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Chemotherapy Market Size and Growth Rate of Hospitals from 2014 to 2026

    • 1.4.2 Europe Chemotherapy Market Size and Growth Rate of Research institutes from 2014 to 2026

    • 1.4.3 Europe Chemotherapy Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Chemotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Chemotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Chemotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Chemotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Chemotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Chemotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Chemotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Chemotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Chemotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Chemotherapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Chemotherapy by Major Types

      • 3.4.1 Market Size and Growth Rate of Paclitaxel

      • 3.4.2 Market Size and Growth Rate of Vincristine

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Chemotherapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Chemotherapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Chemotherapy for Hospitals

      • 4.4.2 Market Size and Growth Rate of Chemotherapy for Research institutes

      • 4.4.3 Market Size and Growth Rate of Chemotherapy for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Chemotherapy Production Analysis by Top Regions

    • 5.2 Europe Chemotherapy Consumption Analysis by Top Regions

    • 5.3 Europe Chemotherapy Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Chemotherapy Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Chemotherapy Production, Import, Consumption and Export Analysis

      • 5.3.3 France Chemotherapy Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Chemotherapy Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Chemotherapy Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Chemotherapy Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Chemotherapy Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Chemotherapy Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Chemotherapy Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy Production, Import, Consumption and Export Analysis

    6 Product Circulation of Chemotherapy Market among Top Countries

    • 6.1 Top 5 Export Countries in Chemotherapy Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Chemotherapy Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Chemotherapy Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Chemotherapy Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Chemotherapy Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Chemotherapy Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Chemotherapy Landscape Analysis

    • 7.1 Germany Chemotherapy Landscape Analysis by Major Types

    • 7.2 Germany Chemotherapy Landscape Analysis by Major End-Users

    8. UK Chemotherapy Landscape Analysis

    • 8.1 UK Chemotherapy Landscape Analysis by Major Types

    • 8.2 UK Chemotherapy Landscape Analysis by Major End-Users

    9. France Chemotherapy Landscape Analysis

    • 9.1 France Chemotherapy Landscape Analysis by Major Types

    • 9.2 France Chemotherapy Landscape Analysis by Major End-Users

    10. Italy Chemotherapy Landscape Analysis

    • 10.1 Italy Chemotherapy Landscape Analysis by Major Types

    • 10.2 Italy Chemotherapy Landscape Analysis by Major End-Users

    11. Spain Chemotherapy Landscape Analysis

    • 11.1 Spain Chemotherapy Landscape Analysis by Major Types

    • 11.2 Spain Chemotherapy Landscape Analysis by Major End-Users

    12. Poland Chemotherapy Landscape Analysis

    • 12.1 Poland Chemotherapy Landscape Analysis by Major Types

    • 12.2 Poland Chemotherapy Landscape Analysis by Major End-Users

    13. Russia Chemotherapy Landscape Analysis

    • 13.1 Russia Chemotherapy Landscape Analysis by Major Types

    • 13.2 Russia Chemotherapy Landscape Analysis by Major End-Users

    14. Switzerland Chemotherapy Landscape Analysis

    • 14.1 Switzerland Chemotherapy Landscape Analysis by Major Types

    • 14.2 Switzerland Chemotherapy Landscape Analysis by Major End-Users

    15. Turkey Chemotherapy Landscape Analysis

    • 15.1 Turkey Chemotherapy Landscape Analysis by Major Types

    • 15.2 Turkey Chemotherapy Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy Landscape Analysis by Top Countries

      • 16.3.1 Denmark Chemotherapy Market Volume and Growth Rate

      • 16.3.2 Finland Chemotherapy Market Volume and Growth Rate

      • 16.3.3 Norway Chemotherapy Market Volume and Growth Rate

      • 16.3.4 Sweden Chemotherapy Market Volume and Growth Rate

      • 16.3.6 Iceland Chemotherapy Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy Landscape Analysis by Top Countries

      • 17.3.1 Belgium Chemotherapy Market Volume and Growth Rate

      • 17.3.2 Netherlands Chemotherapy Market Volume and Growth Rate

      • 17.3.3 Luxembourg Chemotherapy Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy Landscape Analysis by Top Countries

      • 18.3.1 Estonia Chemotherapy Market Volume and Growth Rate

      • 18.3.2 Latvia Chemotherapy Market Volume and Growth Rate

      • 18.3.3 Lithuania Chemotherapy Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 F. Hoffmann-La Roche Ltd.

      • 19.1.1 F. Hoffmann-La Roche Ltd. Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 ALZA Corporation.

      • 19.2.1 ALZA Corporation. Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 OSI Pharmaceuticals, Inc.

      • 19.3.1 OSI Pharmaceuticals, Inc. Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 AstraZeneca PlC

      • 19.4.1 AstraZeneca PlC Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Genentech Inc

      • 19.5.1 Genentech Inc Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Takeda Pharmaceutical Company

      • 19.6.1 Takeda Pharmaceutical Company Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Dendreon Corporation.

      • 19.7.1 Dendreon Corporation. Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Medimmune, LLC

      • 19.8.1 Medimmune, LLC Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Progenics Pharmaceuticals, Inc.

      • 19.9.1 Progenics Pharmaceuticals, Inc. Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Immunomedics, Inc

      • 19.10.1 Immunomedics, Inc Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Cell Genesys Inc.

      • 19.11.1 Cell Genesys Inc. Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Paladin Labs Inc

      • 19.12.1 Paladin Labs Inc Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Bristol-Myers Squibb Company.

      • 19.13.1 Bristol-Myers Squibb Company. Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Indevus Pharmaceuticals Inc

      • 19.14.1 Indevus Pharmaceuticals Inc Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Sanofi-Aventis SA.

      • 19.15.1 Sanofi-Aventis SA. Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 EUSA Pharma, Inc

      • 19.16.1 EUSA Pharma, Inc Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 F Hoffmann-La Roche Ltd

      • 19.17.1 F Hoffmann-La Roche Ltd Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Spectrum Pharmaceuticals, Inc.

      • 19.18.1 Spectrum Pharmaceuticals, Inc. Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Novartis AG (Switzerland).

      • 19.19.1 Novartis AG (Switzerland). Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Pfizer Inc.

      • 19.20.1 Pfizer Inc. Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 GlaxoSmithKline PIC.

      • 19.21.1 GlaxoSmithKline PIC. Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Amgen Inc

      • 19.22.1 Amgen Inc Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    The List of Tables and Figures (Totals 88 Figures and 149 Tables)

    • Figure Product Picture

    • Figure Europe Chemotherapy Market Size and Growth Rate of Paclitaxel from 2014 to 2026

    • Figure Europe Chemotherapy Market Size and Growth Rate of Vincristine from 2014 to 2026

    • Figure Europe Chemotherapy Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Chemotherapy Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Europe Chemotherapy Market Size and Growth Rate of Research institutes from 2014 to 2026

    • Figure Europe Chemotherapy Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure UK Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure France Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Chemotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Chemotherapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Chemotherapy

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Chemotherapy by Different Types from 2014 to 2026

    • Table Consumption Share of Chemotherapy by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Paclitaxel

    • Figure Market Size and Growth Rate of Vincristine

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Chemotherapy by Different End-Users from 2014 to 2026

    • Table Consumption Share of Chemotherapy by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Research institutes

    • Figure Market Size and Growth Rate of Others

    • Table Europe Chemotherapy Production by Major Regions

    • Table Europe Chemotherapy Production Share by Major Regions

    • Figure Europe Chemotherapy Production Share by Major Countries and Regions in 2014

    • Table Europe Chemotherapy Consumption by Major Regions

    • Table Europe Chemotherapy Consumption Share by Major Regions

    • Table Germany Chemotherapy Production, Import, Consumption and Export Analysis

    • Table UK Chemotherapy Production, Import, Consumption and Export Analysis

    • Table France Chemotherapy Production, Import, Consumption and Export Analysis

    • Table Italy Chemotherapy Production, Import, Consumption and Export Analysis

    • Table Spain Chemotherapy Production, Import, Consumption and Export Analysis

    • Table Poland Chemotherapy Production, Import, Consumption and Export Analysis

    • Table Russia Chemotherapy Production, Import, Consumption and Export Analysis

    • Table Switzerland Chemotherapy Production, Import, Consumption and Export Analysis

    • Table Turkey Chemotherapy Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Chemotherapy Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Chemotherapy Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Chemotherapy Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Chemotherapy Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Chemotherapy Consumption by Types from 2014 to 2026

    • Table Germany Chemotherapy Consumption Share by Types from 2014 to 2026

    • Table Germany Chemotherapy Consumption by End-Users from 2014 to 2026

    • Table Germany Chemotherapy Consumption Share by End-Users from 2014 to 2026

    • Table UK Chemotherapy Consumption by Types from 2014 to 2026

    • Table UK Chemotherapy Consumption Share by Types from 2014 to 2026

    • Table UK Chemotherapy Consumption by End-Users from 2014 to 2026

    • Table UK Chemotherapy Consumption Share by End-Users from 2014 to 2026

    • Table France Chemotherapy Consumption by Types from 2014 to 2026

    • Table France Chemotherapy Consumption Share by Types from 2014 to 2026

    • Table France Chemotherapy Consumption by End-Users from 2014 to 2026

    • Table France Chemotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Italy Chemotherapy Consumption by Types from 2014 to 2026

    • Table Italy Chemotherapy Consumption Share by Types from 2014 to 2026

    • Table Italy Chemotherapy Consumption by End-Users from 2014 to 2026

    • Table Italy Chemotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Spain Chemotherapy Consumption by Types from 2014 to 2026

    • Table Spain Chemotherapy Consumption Share by Types from 2014 to 2026

    • Table Spain Chemotherapy Consumption by End-Users from 2014 to 2026

    • Table Spain Chemotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Poland Chemotherapy Consumption by Types from 2014 to 2026

    • Table Poland Chemotherapy Consumption Share by Types from 2014 to 2026

    • Table Poland Chemotherapy Consumption by End-Users from 2014 to 2026

    • Table Poland Chemotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Russia Chemotherapy Consumption by Types from 2014 to 2026

    • Table Russia Chemotherapy Consumption Share by Types from 2014 to 2026

    • Table Russia Chemotherapy Consumption by End-Users from 2014 to 2026

    • Table Russia Chemotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Chemotherapy Consumption by Types from 2014 to 2026

    • Table Switzerland Chemotherapy Consumption Share by Types from 2014 to 2026

    • Table Switzerland Chemotherapy Consumption by End-Users from 2014 to 2026

    • Table Switzerland Chemotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Chemotherapy Consumption by Types from 2014 to 2026

    • Table Turkey Chemotherapy Consumption Share by Types from 2014 to 2026

    • Table Turkey Chemotherapy Consumption by End-Users from 2014 to 2026

    • Table Turkey Chemotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Chemotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Chemotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Chemotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Chemotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Chemotherapy Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Chemotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Chemotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Chemotherapy Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Chemotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Chemotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Chemotherapy Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of F. Hoffmann-La Roche Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche Ltd.

    • Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche Ltd.

    • Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche Ltd.

    • Table Product and Service Introduction of F. Hoffmann-La Roche Ltd.

    • Table Company Profile and Development Status of ALZA Corporation.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ALZA Corporation.

    • Figure Sales and Growth Rate Analysis of ALZA Corporation.

    • Figure Revenue and Market Share Analysis of ALZA Corporation.

    • Table Product and Service Introduction of ALZA Corporation.

    • Table Company Profile and Development Status of OSI Pharmaceuticals, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OSI Pharmaceuticals, Inc.

    • Figure Sales and Growth Rate Analysis of OSI Pharmaceuticals, Inc.

    • Figure Revenue and Market Share Analysis of OSI Pharmaceuticals, Inc.

    • Table Product and Service Introduction of OSI Pharmaceuticals, Inc.

    • Table Company Profile and Development Status of AstraZeneca PlC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca PlC

    • Figure Sales and Growth Rate Analysis of AstraZeneca PlC

    • Figure Revenue and Market Share Analysis of AstraZeneca PlC

    • Table Product and Service Introduction of AstraZeneca PlC

    • Table Company Profile and Development Status of Genentech Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech Inc

    • Figure Sales and Growth Rate Analysis of Genentech Inc

    • Figure Revenue and Market Share Analysis of Genentech Inc

    • Table Product and Service Introduction of Genentech Inc

    • Table Company Profile and Development Status of Takeda Pharmaceutical Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company

    • Table Product and Service Introduction of Takeda Pharmaceutical Company

    • Table Company Profile and Development Status of Dendreon Corporation.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dendreon Corporation.

    • Figure Sales and Growth Rate Analysis of Dendreon Corporation.

    • Figure Revenue and Market Share Analysis of Dendreon Corporation.

    • Table Product and Service Introduction of Dendreon Corporation.

    • Table Company Profile and Development Status of Medimmune, LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medimmune, LLC

    • Figure Sales and Growth Rate Analysis of Medimmune, LLC

    • Figure Revenue and Market Share Analysis of Medimmune, LLC

    • Table Product and Service Introduction of Medimmune, LLC

    • Table Company Profile and Development Status of Progenics Pharmaceuticals, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals, Inc.

    • Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals, Inc.

    • Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals, Inc.

    • Table Product and Service Introduction of Progenics Pharmaceuticals, Inc.

    • Table Company Profile and Development Status of Immunomedics, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunomedics, Inc

    • Figure Sales and Growth Rate Analysis of Immunomedics, Inc

    • Figure Revenue and Market Share Analysis of Immunomedics, Inc

    • Table Product and Service Introduction of Immunomedics, Inc

    • Table Company Profile and Development Status of Cell Genesys Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cell Genesys Inc.

    • Figure Sales and Growth Rate Analysis of Cell Genesys Inc.

    • Figure Revenue and Market Share Analysis of Cell Genesys Inc.

    • Table Product and Service Introduction of Cell Genesys Inc.

    • Table Company Profile and Development Status of Paladin Labs Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Paladin Labs Inc

    • Figure Sales and Growth Rate Analysis of Paladin Labs Inc

    • Figure Revenue and Market Share Analysis of Paladin Labs Inc

    • Table Product and Service Introduction of Paladin Labs Inc

    • Table Company Profile and Development Status of Bristol-Myers Squibb Company.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company.

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company.

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company.

    • Table Product and Service Introduction of Bristol-Myers Squibb Company.

    • Table Company Profile and Development Status of Indevus Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Indevus Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Indevus Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Indevus Pharmaceuticals Inc

    • Table Product and Service Introduction of Indevus Pharmaceuticals Inc

    • Table Company Profile and Development Status of Sanofi-Aventis SA.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis SA.

    • Figure Sales and Growth Rate Analysis of Sanofi-Aventis SA.

    • Figure Revenue and Market Share Analysis of Sanofi-Aventis SA.

    • Table Product and Service Introduction of Sanofi-Aventis SA.

    • Table Company Profile and Development Status of EUSA Pharma, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EUSA Pharma, Inc

    • Figure Sales and Growth Rate Analysis of EUSA Pharma, Inc

    • Figure Revenue and Market Share Analysis of EUSA Pharma, Inc

    • Table Product and Service Introduction of EUSA Pharma, Inc

    • Table Company Profile and Development Status of F Hoffmann-La Roche Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd

    • Table Product and Service Introduction of F Hoffmann-La Roche Ltd

    • Table Company Profile and Development Status of Spectrum Pharmaceuticals, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spectrum Pharmaceuticals, Inc.

    • Figure Sales and Growth Rate Analysis of Spectrum Pharmaceuticals, Inc.

    • Figure Revenue and Market Share Analysis of Spectrum Pharmaceuticals, Inc.

    • Table Product and Service Introduction of Spectrum Pharmaceuticals, Inc.

    • Table Company Profile and Development Status of Novartis AG (Switzerland).

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Switzerland).

    • Figure Sales and Growth Rate Analysis of Novartis AG (Switzerland).

    • Figure Revenue and Market Share Analysis of Novartis AG (Switzerland).

    • Table Product and Service Introduction of Novartis AG (Switzerland).

    • Table Company Profile and Development Status of Pfizer Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc.

    • Figure Sales and Growth Rate Analysis of Pfizer Inc.

    • Figure Revenue and Market Share Analysis of Pfizer Inc.

    • Table Product and Service Introduction of Pfizer Inc.

    • Table Company Profile and Development Status of GlaxoSmithKline PIC.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline PIC.

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline PIC.

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline PIC.

    • Table Product and Service Introduction of GlaxoSmithKline PIC.

    • Table Company Profile and Development Status of Amgen Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc

    • Figure Sales and Growth Rate Analysis of Amgen Inc

    • Figure Revenue and Market Share Analysis of Amgen Inc

    • Table Product and Service Introduction of Amgen Inc

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.